| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 10/21/2004 | WO2004089363A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 10/21/2004 | WO2004089348A2 Use of a serotonin transporter inhibitor for the treatment of pulmonary hypertension |
| 10/21/2004 | WO2004089347A1 Transdermal absorption preparation containing tulobuterol and patch using the same |
| 10/21/2004 | WO2004089292A2 Immunomodulatory agents for treatment of inflammatory diseases |
| 10/21/2004 | WO2004067026A8 Regulation of allergen induced gene |
| 10/21/2004 | WO2004066960A3 Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| 10/21/2004 | WO2004064860A8 Use of tff2, or agents inducing tff2, in the therapy of allergies |
| 10/21/2004 | WO2004024728A3 Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors |
| 10/21/2004 | WO2003097163A3 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions |
| 10/21/2004 | WO2003049599A8 Methods and compositions for the diagnosis of asthma |
| 10/21/2004 | WO2003000014A3 Spherical protein particles and methods of making and using them |
| 10/21/2004 | US20040210052 Efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 10/21/2004 | US20040209948 especially naphthalene sulfonamides, used for treating asthma |
| 10/21/2004 | US20040209938 Novel 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 10/21/2004 | US20040209914 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 10/21/2004 | US20040209908 New derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 10/21/2004 | US20040209901 substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors. |
| 10/21/2004 | US20040209899 A2B adenosine receptor antagonists |
| 10/21/2004 | US20040209894 e.g., 1-(4-chloroanilino)-4-[2-(pyridin-3-yl)-ethyl]-isoquinoline and 5-[4-(tert-butyl)-anilino]-8-[(6-methoxy-pyridin-3-yl)-methyl]-[1,6]naphthyridine |
| 10/21/2004 | US20040209893 treatment of a condition mediated by a tachykinin including substance P and other neurokinins by administering N-benzyl-2-phenylpiperazine-1-carboxamides, e.g., 2-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid (3,5-bistrifuoromethyl-benzyl)-methyl-amide Hydrochloride . |
| 10/21/2004 | US20040209879 Piperidinyl derivates as modulators of chemokine receptor activity |
| 10/21/2004 | US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 10/21/2004 | US20040209868 Substituted indoles |
| 10/21/2004 | US20040209852 Formulations and methods for treating rhinosinusitis |
| 10/21/2004 | US20040209843 addtion of a cyclodextrin compound increases the water solubility; storage stable solution; immediately treating symptoms of acute phases of myocardial or a cerebral infarction |
| 10/21/2004 | US20040209806 controlling trefoil factor-2 (TFF2) expression; for reducing acid secretion and/or increasing epithelial cell proliferation to promote healing; lung assessment |
| 10/21/2004 | US20040209805 such as fibrosis via activin antagonist (fullistatin); kits; gene therapy; treating inflammatory bowel disease and crohn's disease |
| 10/21/2004 | US20040208941 Compositions for removal of toxins |
| 10/21/2004 | US20040208924 active pharmaceutical ingredient is for example [(2S)-Sulfanyl-5-[(N,N-dimethylamino)acetyl]aminopentanoyl-L-leucyl-L-tert-leucine N-methylamide; bonding strength, stability |
| 10/21/2004 | US20040208889 Pharmaceutical use for secreted bacterial effector proteins |
| 10/21/2004 | US20040208888 Method of and compositions for immunization with the pseudomonas v antigen |
| 10/21/2004 | US20040208878 Treatment of acute lung injury, fibrosis and metastasis with antagonists of alphabetav6 |
| 10/21/2004 | CA2522071A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 10/21/2004 | CA2521989A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 10/21/2004 | CA2521788A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 10/21/2004 | CA2521340A1 Aminopyrimidine derivatives and their medical use |
| 10/20/2004 | EP1469077A1 Cell-specific expression/replication vector |
| 10/20/2004 | EP1468998A1 Crystalline monohydrate of Tiotropium bromide and process for its preparation |
| 10/20/2004 | EP1468991A1 Imides as PDE III, PDE IV and TNF inhibitors |
| 10/20/2004 | EP1468019A2 Secreted protein |
| 10/20/2004 | EP1468018A2 Leptin proteins |
| 10/20/2004 | EP1467995A2 Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 10/20/2004 | EP1467994A1 Pteridine derivatives, method for the production thereof, and use thereof |
| 10/20/2004 | EP1467993A1 Method for producing scopine esters |
| 10/20/2004 | EP1467982A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof |
| 10/20/2004 | EP1467976A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 10/20/2004 | EP1467972A1 Indazole compounds useful as protein kinase inhibitors |
| 10/20/2004 | EP1467762A1 Use of an h1 antagonist and a safe steroid to treat rhinitis |
| 10/20/2004 | EP1467752A1 HUMAN MAST CELL−EXPRESSED MEMBRANE PROTEINS |
| 10/20/2004 | EP1467745A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 10/20/2004 | EP1467733A1 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as beta3 agonists |
| 10/20/2004 | EP1467728A1 Pharmaceutical compositions comprising valsartan and nep inhibitors |
| 10/20/2004 | EP1467721A2 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 10/20/2004 | EP1467714A1 Drug mixture with enhanced dissolution rate |
| 10/20/2004 | EP1309503B1 Medical spray device |
| 10/20/2004 | EP1289964B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 10/20/2004 | EP1263725B1 Novel compounds |
| 10/20/2004 | EP1246619B1 Urotensin-ii receptor antagonists |
| 10/20/2004 | EP1230236B1 Compound with growth hormone releasing properties |
| 10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 10/20/2004 | EP1151008B1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 10/20/2004 | EP1131291B1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 10/20/2004 | EP1073440B1 sPLA 2 INHIBITOR ESTERS |
| 10/20/2004 | EP0830136B1 New cryptophycins from synthesis |
| 10/20/2004 | CN1539010A Fermentation product of cryptoporus volvatus and its preparation method and application |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |
| 10/20/2004 | CN1538969A Novel benzothienyl or indole derivatives, preparation and use thereof as inhibitors of prenyl transferase proteins |
| 10/20/2004 | CN1538960A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containint them |
| 10/20/2004 | CN1538959A Fused-polycyclic compounds |
| 10/20/2004 | CN1538956A Spiro compounds |
| 10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 10/20/2004 | CN1538853A T cell regulatory genes and methods of use thereof |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538844A Novel amides preparation used as modulators of CCR-receptor activity, its preparation and therapeutic use |
| 10/20/2004 | CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 10/20/2004 | CN1538836A Substituted amine derivatives and method of use |
| 10/20/2004 | CN1537626A Pill for treating lung disease, and its prepn. method |
| 10/20/2004 | CN1537625A Traditional Chinese medicine tablet prepn. method |
| 10/20/2004 | CN1537597A Folium artemisiae argyi oil dripping pills, and its prepn. method |
| 10/20/2004 | CN1537596A Folium artemisiae argyi oil soft capsule, and its prepn. metod |
| 10/20/2004 | CN1537593A Xiaoer Niuhuang Qingfei, granule contg. bezoar for cleaning-away lung-heat of children and its prepn.method |
| 10/20/2004 | CN1537592A Yinqin tablet contg. Chinese medicines, and its prepn. method |
| 10/20/2004 | CN1537591A Yinqin Granule contg. Chinese medicines, and its prepn. method |
| 10/20/2004 | CN1537590A Xiaoke capsule for relieving cough, and its prepn. method |
| 10/20/2004 | CN1537589A Xiaoke dispersing tablet for relieving cough and its prepn. method |
| 10/20/2004 | CN1537587A Sanhuang qingjie granule contg. coptis, phellodendroum and others for cleaning-away heat and detoxifying, and its prepn. method |
| 10/20/2004 | CN1537586A Sanhuang Qingjie dispersing tablet contg. coptis, phellodendronum and others for cleaning heat and detoxicating, and its prepn. method |
| 10/20/2004 | CN1537577A Xiaoer Niuhuang Qingfei Fensan Contg. bezoar for cleaning lung of children, and its prepn. method |
| 10/20/2004 | CN1537537A Method for preparing nucleic acid hydrolysate contained in Heluo (nucleic junket) oral liquid |
| 10/20/2004 | CN1537532A Pyridoxin and application of its derivatives in preparation of medicine |
| 10/20/2004 | CN1537531A Celecoxib compositions |
| 10/20/2004 | CN1171996C American pig reproduction and respiratory syndrome syndrome (PRRS) virus and its use |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171887C Respiratory syncytial virus replication inhibitors |
| 10/20/2004 | CN1171883C Nonsteroidal antiinflammatories |
| 10/20/2004 | CN1171606C Watermelon frost and its preparing method |
| 10/20/2004 | CN1171601C Medicine for treating nephrosis and lung disease |
| 10/19/2004 | US6806370 NK-1 receptor active amine oxide prodrugs |
| 10/19/2004 | US6806312 Thermoplastic resin composition |